The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences.

Finally, an analysis of tumours with germline pathogenic variants in six high to moderate breast cancer susceptibility genes did not reveal any significant differences between our cohort and TCGA 26 , except for a marginally significant higher prevalence in germline PALB2 mutations (Supplementary Table 4 ).

also in 26,082 other papers